"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LIVER.
Descriptor ID |
D008113
|
MeSH Number(s) |
C04.588.274.623 C06.301.623 C06.552.697
|
Concept/Terms |
Liver Neoplasms- Liver Neoplasms
- Neoplasms, Hepatic
- Neoplasms, Liver
- Liver Neoplasm
- Neoplasm, Liver
- Hepatic Neoplasms
- Hepatic Neoplasm
- Neoplasm, Hepatic
Cancer of Liver- Cancer of Liver
- Hepatocellular Cancer
- Cancers, Hepatocellular
- Hepatocellular Cancers
- Hepatic Cancer
- Cancer, Hepatic
- Cancers, Hepatic
- Hepatic Cancers
- Liver Cancer
- Cancer, Liver
- Cancers, Liver
- Liver Cancers
- Cancer of the Liver
- Cancer, Hepatocellular
|
Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".
This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 4 | 6 |
1996 | 4 | 3 | 7 |
1997 | 1 | 2 | 3 |
1998 | 1 | 3 | 4 |
1999 | 1 | 3 | 4 |
2000 | 3 | 4 | 7 |
2001 | 6 | 1 | 7 |
2002 | 9 | 4 | 13 |
2003 | 5 | 4 | 9 |
2004 | 11 | 6 | 17 |
2005 | 10 | 4 | 14 |
2006 | 4 | 3 | 7 |
2007 | 15 | 4 | 19 |
2008 | 13 | 4 | 17 |
2009 | 17 | 6 | 23 |
2010 | 22 | 5 | 27 |
2011 | 18 | 3 | 21 |
2012 | 21 | 3 | 24 |
2013 | 25 | 2 | 27 |
2014 | 22 | 3 | 25 |
2015 | 24 | 3 | 27 |
2016 | 29 | 3 | 32 |
2017 | 28 | 4 | 32 |
2018 | 34 | 4 | 38 |
2019 | 43 | 6 | 49 |
2020 | 52 | 3 | 55 |
2021 | 44 | 3 | 47 |
2022 | 61 | 1 | 62 |
2023 | 49 | 2 | 51 |
2024 | 40 | 8 | 48 |
2025 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.
-
Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct-Acting Antivirals Versus Interferon. Aliment Pharmacol Ther. 2025 Apr; 61(7):1226-1237.
-
Benefits and harms of hepatocellular carcinoma screening outreach in patients with cirrhosis: a multicenter randomized clinical trial. J Natl Cancer Inst. 2025 Feb 01; 117(2):262-269.
-
Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2025 Feb 01; 11(2):136-144.
-
Debate: Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments. Hematol Oncol Clin North Am. 2025 Feb; 39(1):207-220.
-
Risk of carcinomas among children and adolescents with birth defects. Cancer Epidemiol. 2025 Apr; 95:102748.
-
"Update on pediatric primary liver tumors". Virchows Arch. 2025 Jan; 486(1):23-47.
-
Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2025 Apr; 32(4):2425-2434.
-
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis. Cancer Res. 2025 Jan 15; 85(2):299-313.
-
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer. Nat Cancer. 2025 Jan; 6(1):123-144.
-
Access to Evaluation for Liver Transplantation in the Veterans Health Administration. Dig Dis Sci. 2025 Feb; 70(2):552-565.